Skip to content
lifestyle.lincolnlabs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CO-DIAGNOSTICS
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
July 1, 2026
Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
June 25, 2026
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
June 18, 2026
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
May 26, 2026
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
May 19, 2026
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
May 19, 2026
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia’s Sudair Industrial City
May 8, 2026
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
April 30, 2026
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
April 16, 2026
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
April 14, 2026
1
2
3
Next Page
→